VENTURA-7
Major Depressive Disorder (MDD)
Phase 2/3Active
Key Facts
Indication
Major Depressive Disorder (MDD)
Phase
Phase 2/3
Status
Active
Company
About New Hope Clinical Research
New Hope Clinical Research is a privately-held clinical trial site management organization with a nearly 20-year operational history in Charlotte, NC. It provides clinical trial execution services for pharmaceutical and biotechnology sponsors, operating a Phase I-IV unit that has successfully passed an FDA audit with no deficiencies. The company focuses on central nervous system disorders and oncology, leveraging its experienced team and facility to participate in mid-to-late-stage clinical studies, as evidenced by its ongoing involvement in depression and historical Alzheimer's trials.
View full company profileTherapeutic Areas
Other Major Depressive Disorder (MDD) Drugs
| Drug | Company | Phase |
|---|---|---|
| AL001 | Alzamend Neuro | Preclinical |
| Deep TMS (H1 Coil) | BrainsWay | FDA Cleared |
| EXXUA™ (gepirone ER) | Aytu BioPharma | Commercial |
| ZZ6398 | Zhongze Therapeutics | Phase 1/2 |
| INV-202 (Oral & LAI) | Indivior | Preclinical |
| NeuroStar Advanced Therapy | Neuronetics | FDA Cleared |
| Gepirone ER | Fabre-Kramer Pharmaceuticals | NDA Submitted |
| Exablate Neuro | Insightec | Clinical Trial |
| BrightKaire Platform for Depression | NeuroKaire | Pre-clinical |
| Tyemvers (CKDB-501) | Healis Therapeutics | Pre-clinical |
| DT-101 | Draig Therapeutics | Phase 2 |
| Major Depressive Disorder Program | Actipulse Neuroscience | Phase 3 |